MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

FYN expression is associated with regulatory region genetic variation

L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz (Cleveland, OH, USA)

Meeting: 2016 International Congress

Abstract Number: 1344

Keywords: Dementia, Tauopathies

Session Information

Date: Wednesday, June 22, 2016

Session Title: Cognitive disorders

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The hypothesis of this investigation was that FYN expression and promoter activity are significantly influenced according to genetic content. The objective of this investigation was to produce a library of FYN regulatory region haplotype reporter constructs and compare their expression in multiple human neuronal and astroglial cell lines.

Background: Evidence suggests that Fyn, a tyrosine kinase, may be involved in aberrant tau phosphorylation in AD and is elevated in AD brain compared to controls. Extracellular oligomeric Aβ, cellular prion protein and Fyn coupling are implicated in an intracellular signaling cascade which may in turn influence tau expression. Our previous study found an association between a SNP in the 5′ region of FYN and cerebrospinal fluid (CSF) tau levels in AD suggesting that FYN regulatory region genetic content may play a role in AD elevated CSF tau. Since it has been proposed that FYN expression might be a target for AD therapeutic strategies, it is important to tease apart the cis-acting functional components of this genetic signal.

Methods: The FYN promoter and 3′ region of 3 different FYN isoforms (from genomic DNA) were inserted into reporter vectors in various haplotype combinations. This created 9 FYN promoter regulatory region haplotype reporters and 24 FYN promoter plus 3’UTR regulatory region haplotype reporters. A total of 33 regulatory region haplotype reporters were transfected into multiple human cell lines to compare their expression.

Results: Results indicate that there is a significant difference in: 1) FYN isoform activity that varies according to cell type, 2) FYN promoter activity variation according to haplotype and cell type and 3) 3′ UTR inhibition of promoter activity according to haplotype.

Conclusions: These results suggest that FYN expression is significantly influenced by regulatory region genetic content. Teasing apart the cis-acting functional components of AD genes, such as FYN, will enhance our knowledge of AD as well as inform AD prediction and therapeutic modalities.

To cite this abstract in AMA style:

L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz. FYN expression is associated with regulatory region genetic variation [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/fyn-expression-is-associated-with-regulatory-region-genetic-variation/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/fyn-expression-is-associated-with-regulatory-region-genetic-variation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley